News and Trends 20 Jul 2021 Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene …big focus on treating Alzheimer’s disease. The frequently-debated amyloid hypothesis attributes this complex condition to the buildup of a protein called amyloid-beta in the brain. However, some people with a buildup… July 20, 2021 - 4 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 May 2024 Eight monoclonal antibody biotechs making strides in the clinic …raised $125 million. BioArctic On a mission to advance its robust pipeline that includes Alzheimer’s drug lecanemab, which was approved by the FDA last year, Swedish biotech BioArctic is focused… May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2021 The 21 European Biotech Companies To Watch in 2021 …Location: Paris, France AB Science ended 2020 on a high after its drug masitinib prevented patients with moderate symptoms of Alzheimer’s disease from progressing to severe dementia in a phase… January 11, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 Lifesciences and biotech in 2023 …sepsis, and on educating health care providers in effective identification and treatment of sepsis. The challenges mentioned above in tackling AMR also limit progress in battling sepsis. Alzheimer’s disease will… January 11, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2022 Biogen, citing insurance challenges, shutters one of its Aduhelm studies A company says it was forced to end an observational trial of Alzheimer’s drug, Aduhelm, after a ruling by US federal insurance program, Medicare. Biogen said a recent coverage decision… June 28, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jun 2022 Boost for dementia gene-based therapies …2017 by the Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK, the Institute is hosted across six UK universities: University of Cambridge, Cardiff University, University of Edinburgh, Imperial College… June 20, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 3 Nov 2022 What’s on the horizon for gene editing-based therapies? …less clear. “We don’t yet have a broad handle on the underlying genetics,” noted Smith. “Alzheimer’s disease is probably not one disease; it’s probably 55 small diseases each having different… November 3, 2022 - 8 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 10 May 2019 This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins …… The beauty of these more natural approaches is that you get higher efficacy and lower toxicity.” Some companies are developing PROTAC drugs to tackle neurodegenerative diseases such as Alzheimer’s…. May 10, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 7 Jun 2021 The Post-Covid Future of AI for Drug Development …a startup that uses language recognition to detect Alzheimer’s. “One aspect of AI that is still problematic is neural networks and their lack of transparency for health applications. To trust… June 7, 2021 - 11 minutesmins - By Matthew Williams Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2017 What are the Best Countries to Recruit Biotech Talents in 2017? …innovative therapies for Alzheimer’s disease and its last private fundraising reached €120M. Number of Employees in Biotech: 37k Number of Employees in Life Sciences: 247k Number of Biotech Companies:… March 15, 2017 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2017 Biotech from the Bermuda Islands Brings Good News for Dementia Patients …Phase II for REM sleep behavior disorder (RBD), and the company intends to initiate programs for psychosis in Alzheimer’s and Parkinson’s. The company’s lead candidate, intepirdine (RVT-101), was also acquired… February 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 28 May 2021 Startup Creator Launched to Fill Europe’s Microbiome Translational Gap …phase III trials, joining a growing class of drug candidates for indications like chemotherapy-related infections and Alzheimer’s disease. While incubators, venture funds, and accelerators address part of the translational gap,… May 28, 2021 - 6 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email